Clinical Trial Update: Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals [Phase 3]

View source ↗

Summary

Phase 3 trial update on safety and efficacy of Zidovudine for asymptomatic HIV-infected individuals has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED